In androgen-responsive NCaP prostate cancer cells, Capsaicin, a TRPV1 agonist, was found to enhance TRPV1-dependent cell proliferation through Akt and ERK pathways [216]. This evidence concerns the gene TRPV1 and prostate cancer.